Detail
| LncRNA Name | LINC00961 |
| Synonyms | SPAAR, LINC00961, SPARï¼?lin-RECK-3 |
| Region | GRCh38_9:35909483-35937153 Sequence |
| Ensembl | ENSG00000235387 |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | RNA-seq, qPCR, Western blot etc. |
| Sample | cell lines (A2780, A2780-DR) |
| Expression Pattern | up-regulated |
| Function Description | Here, we showed that expression of lin-RECK-3, H19, LUCAT1, LINC00961, and linc-CARS2-2 was enhanced in cisplatin-resistant A2780-DR cells, Lin-RECK-3, H19, LUCAT1, LINC00961, and linc-CARS2-2 showed significantly increased expression levels in A2780-DR cells. |
| Pubmed ID | 27193186 |
| Year | 2016 |
| Title | The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer. |
| External Links |
| Links for LINC00961 | GenBank HGNC lncrnadb Noncode |
| Links for ovarian cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.